Chemcrux Enterprises Q1 Results
- BSE: 540395
- NSE: CHEMCRUX
- ISIN: INE298W01016
- Sector: Biotechnology & Drugs
BSE
83.64
-0.44 (-0.52%)
-0.44 (-0.52%)Volume325.00
Updated: Mon 12 Oct, 2026 | 14:59:22
NSE
82.65-1.09 (-1.30%)
-1.09 (-1.30%)Volume1.19 K
Updated: Mon 12 Oct, 2026 | 15:27:27
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹21.94 Cr.(32.93%)
- Operating Profit₹1.51 Cr.(237.29%)
- Profit After Tax₹0.51 Cr.(445.57%)
- Operating Margin6.89%(153.73%)
Note: Comparison is on YoY basis
Quarterly - Chemcrux Enterprises Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 20.43 | 21.27 | -3.96% | 16.06 | 27.22% |
| Depreciation/ Amortization | 1.18 | 1.17 | 0.89% | 1.18 | 0.62% |
| Operating Income | 1.51 | 3.01 | -49.83% | 0.45 | 237.29% |
| Net Income | 0.51 | 1.85 | -72.68% | 0.09 | 445.57% |
| Other Operating Expenses Total | 6.52 | 8.23 | -20.71% | 4.77 | 36.79% |
| Net Income Before Taxes | 0.98 | 2.67 | -63.23% | 0.03 | 3077.02% |
| Total Revenue | 21.94 | 24.28 | -9.65% | 16.50 | 32.93% |
| Selling/ General/ Admin Expenses Total | 2.70 | 2.63 | 2.63% | 2.13 | 26.66% |
| Diluted Normalized EPS | 0.34 | 1.25 | -72.80% | 0.06 | 466.67% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.